Skip to Content

30 (Lansoprazole Delayed-Release (Orally Disintegrating) 30 mg)

Pill with imprint 30 is White, Round and has been identified as Lansoprazole Delayed-Release (Orally Disintegrating) 30 mg. It is supplied by Teva Pharmaceuticals USA, Inc..

Lansoprazole is used in the treatment of barrett's esophagus; duodenal ulcer; duodenal ulcer prophylaxis; gerd; erosive esophagitis and belongs to the drug class proton pump inhibitors. There is no proven risk in humans during pregnancy. Lansoprazole 30 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 30

Lansoprazole delayed-release (orally disintegrating) 30 mg 30

Lansoprazole Delayed-Release (Orally Disintegrating)

Imprint
30
Strength
30 mg
Color
White
Size
11.00 mm
Shape
Round
Availability
Rx and/or OTC
Drug Class
Proton pump inhibitors
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Teva Pharmaceuticals USA, Inc.
National Drug Code (NDC)
00093-3009
Inactive Ingredients
aspartame, hypromellose 2910 (6 mPa.s), lactose monohydrate, magnesium carbonate, magnesium stearate, corn starch, methacrylic acid - ethyl acrylate copolymer (1:1) type a, microcrystalline cellulose, ethyl butyrate, ethyl isovalerate, acacia, maltodextrin, methyl cinnamate, triethyl citrate, magnesium silicate, titanium dioxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related Images for "30"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.